
US Transthyretin Amyloidosis Treatment Market Rising Growth Due to Advancements in Rare Disease Therapies with CAGR 9.6%
BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The U.S. transthyretin amyloidosis treatment market is estimated to be valued at USD 65.4 Mn in 2025 and is expected to reach USD 124.4 Mn by 2032, exhibiting a compound annual growth …